In America today, doctors are trained that there are just two potential solutions to any problem. Either you prescribe a pill or you cut someone open. Surgery and drugs are pretty much the only alternatives they offer us.
Since the 1998 election cycle, employees of the pharmaceutical and health product industry, their family members and industry political action committees have given $133 million in campaign contributions to candidates running for federal and state offices.
Robert Wood Johnson Foundation authorized $99 million in grants to the American Cancer Society; the American Heart Association and the American Lung Association towards advocacy of non-smoking. RWJF was founded and run by the CEO and other board members of Johnson & Johnson, the manufacturers of Nicoderm and other smoking cessation products. J&J has also acquired Pfizer.
Shortly after, in February 1996, an FDA dental-products panel said the agency was working closely on a new cancer study with the Triclosan Industry Alliance -- a trade group whose members, according to documents on the FDA’s website, included Colgate, Procter & Gamble and Ciba Specialty Chemicals.
Mapp Biopharmaceutical Inc., which has nine employees, released its experimental ZMapp drug, until now only tested on infected animals, for the two health workers. Kentucky BioProcessing LLC, a subsidiary of tobacco giant Reynolds American Inc. (RAI), manufactures the treatment for Mapp from tobacco plants.